KalGene Pharmaceuticals
0 followers
‌
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Nickolay V. Kukekov
President & CEO
Nickolay V. Kukekov
Collapse
